Vanessa Smith

Research interests

Publications

• Systemic sclerosis

  The Lancet · 2022 · 10.1016/s0140-6736(22)01692-0

• Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)

  The Lancet Rheumatology · 2021 · https://doi.org/10.1016/s2665-9913(21)00244-7

• Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

  The Lancet Respiratory Medicine · 2020 · https://doi.org/10.1016/s2213-2600(20)30318-0

• Predictors of progression in systemic sclerosis patients with interstitial lung disease

  European Respiratory Journal · 2020 · 10.1183/13993003.02026-2019

• Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis

  Autoimmunity Reviews · 2020 · 10.1016/j.autrev.2020.102458

• Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study

  Annals of the Rheumatic Diseases · 2019 · https://doi.org/10.1136/annrheumdis-2018-214816

• Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review

  Autoimmunity Reviews · 2019 · 10.1016/j.autrev.2019.102397

• Pathophysiology of systemic sclerosis: current understanding and new insights

  Expert Review of Clinical Immunology · 2019 · 10.1080/1744666x.2019.1614915

• Fast track algorithm: How to differentiate a “scleroderma pattern” from a “non-scleroderma pattern”

  Autoimmunity Reviews · 2019 · 10.1016/j.autrev.2019.102394

• A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement

  Respiratory Research · 2018 · 10.1186/s12931-018-0891-z

• Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening

  The Journal of Rheumatology · 2017 · https://doi.org/10.3899/jrheum.160817

• European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes

  Journal of the European Academy of Dermatology and Venereology · 2017 · https://doi.org/10.1111/jdv.14458

• The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review

  Autoimmunity Reviews · 2017 · 10.1016/j.autrev.2017.05.024

• European dermatology forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis

  Journal of the European Academy of Dermatology and Venereology · 2017 · https://doi.org/10.1111/jdv.14466

• Mapping and predicting mortality from systemic sclerosis

  Annals of the Rheumatic Diseases · 2017 · https://doi.org/10.1136/annrheumdis-2017-211448

• Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis: A Multicenter, Prospective Cohort Study

  Arthritis & Rheumatology · 2016 · 10.1002/art.39718

• Update of EULAR recommendations for the treatment of systemic sclerosis

  Annals of the Rheumatic Diseases · 2016 · https://doi.org/10.1136/annrheumdis-2016-209909

• Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

  Annals of the Rheumatic Diseases · 2014 · 10.1136/annrheumdis-2013-204522

• How to perform and interpret capillaroscopy

  Best Practice & Research Clinical Rheumatology · 2013 · 10.1016/j.berh.2013.03.001

• Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

  New England Journal of Medicine · 2013 · 10.1056/nejmoa1114576

• Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study

  Annals of the Rheumatic Diseases · 2012 · 10.1136/annrheumdis-2011-200780

• Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy

  PLoS Genetics · 2011 · https://doi.org/10.1371/journal.pgen.1002178

• Assessing microvascular changes in systemic sclerosis diagnosis and management

  Nature Reviews Rheumatology · 2010 · 10.1038/nrrheum.2010.104

• Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

  Annals of the Rheumatic Diseases · 2010 · https://doi.org/10.1136/ard.2010.136929

• Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

  Nature Genetics · 2010 · https://doi.org/10.1038/ng.565

• Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study

  Annals of the Rheumatic Diseases · 2008 · 10.1136/ard.2008.095463

• The minimally conscious state and recovery potential: A follow-up study 2 to 5 years after traumatic brain injury

  Archives of Physical Medicine and Rehabilitation · 2005 · 10.1016/j.apmr.2004.11.004

• Validation of the NPI-Q, a Brief Clinical Form of the Neuropsychiatric Inventory

  Journal of Neuropsychiatry · 2000 · 10.1176/jnp.12.2.233

Current projects

No projects listed.